Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by argentia77on Mar 25, 2016 3:51pm
145 Views
Post# 24701045

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The Comapny Performed, Management disappointed.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The Comapny Performed, Management disappointed. I have no idea why Mr. Edward Borkowski refused to answer Prakask Gowd's question during the cc about the 60 new product launches. Maybe he just didn't know (unlikely). So I think it's reasonable to assume they are all reformulations based on drugs that have already been approved and sold. It takes years for a new drug to go through various clinical trials and get approved, let alone 60! Nevertheless launching 60 new formulations in the global market is important and should add signifcant revs to Concordia's bottom line in the years to come.    
<< Previous
Bullboard Posts
Next >>